Advancing mRNA Therapeutics with Targeted LNP Delivery: From Platform Innovation to Clinical Translation
2:00 pm - Thursday 1st October 2026
- Broad mRNA application experience – Development experience across various mRNA applications provides an application-driven foundation for addressing diverse mRNALNP development challenges
- Targeted LNP platform for in vivo CAR – A robust tLNP platform combining antibody conjugation, formulation development, and cell-targeted delivery enables the development of next-generation in vivo CAR therapies
- From platform to clinical translation – case studies to demonstrate how integrated mRNA-LNP capabilities can help accelerate the translation of promising concepts from early research toward clinical development
